| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 1.27e-06 | 2 | 23 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 1.27e-06 | 2 | 23 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 2.66e-05 | 7 | 23 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 2.66e-05 | 7 | 23 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 5.68e-05 | 10 | 23 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 5.68e-05 | 10 | 23 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 5.68e-05 | 10 | 23 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 9.82e-05 | 13 | 23 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate binding | 1.32e-04 | 15 | 23 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 1.51e-04 | 16 | 23 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 1.51e-04 | 16 | 23 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.75e-04 | 1189 | 23 | 7 | GO:0046914 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 3.45e-04 | 24 | 23 | 2 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 4.38e-04 | 27 | 23 | 2 | GO:0008391 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 4.71e-04 | 28 | 23 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | aromatase activity | 7.38e-04 | 35 | 23 | 2 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.44e-03 | 49 | 23 | 2 | GO:0016712 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.84e-03 | 69 | 23 | 2 | GO:0005504 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 6.69e-03 | 107 | 23 | 2 | GO:0033293 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 7.69e-03 | 115 | 23 | 2 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 9.30e-03 | 127 | 23 | 2 | GO:0016616 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 2.96e-06 | 3 | 21 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | striatal medium spiny neuron differentiation | 5.92e-06 | 4 | 21 | 2 | GO:0021773 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 8.92e-05 | 14 | 21 | 2 | GO:0097267 | |
| GeneOntologyBiologicalProcess | medium-chain fatty acid metabolic process | 1.03e-04 | 15 | 21 | 2 | GO:0051791 | |
| GeneOntologyBiologicalProcess | striatum development | 2.25e-04 | 22 | 21 | 2 | GO:0021756 | |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 2.47e-04 | 23 | 21 | 2 | GO:0043651 | |
| GeneOntologyBiologicalProcess | GABAergic neuron differentiation | 2.69e-04 | 24 | 21 | 2 | GO:0097154 | |
| GeneOntologyBiologicalProcess | subpallium development | 3.67e-04 | 28 | 21 | 2 | GO:0021544 | |
| GeneOntologyBiologicalProcess | positive regulation of isotype switching | 4.51e-04 | 31 | 21 | 2 | GO:0045830 | |
| GeneOntologyBiologicalProcess | glutamate metabolic process | 6.79e-04 | 38 | 21 | 2 | GO:0006536 | |
| MousePheno | increased renal vascular resistance | 1.39e-05 | 5 | 17 | 2 | MP:0005531 | |
| MousePheno | abnormal renal sodium reabsorption | 1.39e-05 | 5 | 17 | 2 | MP:0010109 | |
| MousePheno | abnormal renal vascular resistance | 3.88e-05 | 8 | 17 | 2 | MP:0005529 | |
| MousePheno | abnormal medium spiny neuron morphology | 3.88e-05 | 8 | 17 | 2 | MP:0008462 | |
| MousePheno | abnormal renal sodium ion transport | 3.88e-05 | 8 | 17 | 2 | MP:0011442 | |
| MousePheno | salt-sensitive hypertension | 6.23e-05 | 10 | 17 | 2 | MP:0004217 | |
| MousePheno | abnormal body water content | 9.12e-05 | 12 | 17 | 2 | MP:0000676 | |
| MousePheno | abnormal striatum morphology | 9.56e-05 | 75 | 17 | 3 | MP:0004077 | |
| MousePheno | abnormal vascular resistance | 2.35e-04 | 19 | 17 | 2 | MP:0005532 | |
| MousePheno | decreased urine potassium level | 2.35e-04 | 19 | 17 | 2 | MP:0005618 | |
| MousePheno | abnormal basal ganglion morphology | 2.67e-04 | 106 | 17 | 3 | MP:0006007 | |
| MousePheno | abnormal renal transport | 3.47e-04 | 23 | 17 | 2 | MP:0011417 | |
| MousePheno | oliguria | 3.78e-04 | 24 | 17 | 2 | MP:0003620 | |
| MousePheno | decreased urine output | 7.19e-04 | 33 | 17 | 2 | MP:0031358 | |
| MousePheno | abnormal renal reabsorption | 8.09e-04 | 35 | 17 | 2 | MP:0010107 | |
| MousePheno | abnormal urine potassium level | 8.56e-04 | 36 | 17 | 2 | MP:0004820 | |
| Domain | DUF4195 | 8.69e-06 | 4 | 23 | 2 | IPR025243 | |
| Domain | DUF4195 | 8.69e-06 | 4 | 23 | 2 | PF13836 | |
| Domain | Cyt_P450_E_grp-I | 1.39e-03 | 45 | 23 | 2 | IPR002401 | |
| Domain | Cyt_P450_CS | 1.92e-03 | 53 | 23 | 2 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 2.22e-03 | 57 | 23 | 2 | PS00086 | |
| Domain | - | 2.30e-03 | 58 | 23 | 2 | 1.10.630.10 | |
| Domain | p450 | 2.30e-03 | 58 | 23 | 2 | PF00067 | |
| Domain | Cyt_P450 | 2.46e-03 | 60 | 23 | 2 | IPR001128 | |
| Domain | RNaseH-like_dom | 3.24e-03 | 69 | 23 | 2 | IPR012337 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 3.79e-05 | 9 | 15 | 2 | M39819 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 5.78e-05 | 11 | 15 | 2 | MM14863 | |
| Pathway | REACTOME_EICOSANOIDS | 6.93e-05 | 12 | 15 | 2 | MM14845 | |
| Pathway | REACTOME_EICOSANOIDS | 6.93e-05 | 12 | 15 | 2 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 6.93e-05 | 12 | 15 | 2 | M27128 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 9.55e-05 | 14 | 15 | 2 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.10e-04 | 15 | 15 | 2 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.60e-04 | 18 | 15 | 2 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.60e-04 | 18 | 15 | 2 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.19e-04 | 21 | 15 | 2 | M27137 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.13e-04 | 25 | 15 | 2 | MM14858 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX | 4.22e-04 | 29 | 15 | 2 | M39858 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 4.83e-04 | 31 | 15 | 2 | M39851 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 5.47e-04 | 33 | 15 | 2 | MM1448 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 5.47e-04 | 33 | 15 | 2 | MM15963 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 5.47e-04 | 33 | 15 | 2 | MM15918 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 5.81e-04 | 34 | 15 | 2 | M16393 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 8.88e-04 | 42 | 15 | 2 | M699 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 1.69e-03 | 58 | 15 | 2 | M5410 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.75e-03 | 59 | 15 | 2 | M27140 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.87e-03 | 61 | 15 | 2 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.93e-03 | 62 | 15 | 2 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.05e-03 | 64 | 15 | 2 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.05e-03 | 64 | 15 | 2 | M9488 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.18e-03 | 66 | 15 | 2 | MM14839 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 2.38e-03 | 69 | 15 | 2 | M13088 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 2.66e-03 | 73 | 15 | 2 | MM15995 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 2766933 | ||
| Pubmed | Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. | 4.18e-07 | 2 | 23 | 2 | 29277328 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 15611369 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 17112342 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 21820496 | ||
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 4.18e-07 | 2 | 23 | 2 | 11320253 | |
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 4.18e-07 | 2 | 23 | 2 | 23641057 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 23825080 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 16691295 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 8031839 | ||
| Pubmed | Characterization of the CYP4A11 gene, a second CYP4A gene in humans. | 4.18e-07 | 2 | 23 | 2 | 12464262 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 3829886 | ||
| Pubmed | Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. | 4.18e-07 | 2 | 23 | 2 | 20943934 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 10860550 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 28912346 | ||
| Pubmed | High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE. | 4.18e-07 | 2 | 23 | 2 | 30088983 | |
| Pubmed | Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta. | 4.18e-07 | 2 | 23 | 2 | 15066132 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 24413902 | ||
| Pubmed | Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. | 4.18e-07 | 2 | 23 | 2 | 19208908 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 19713718 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 8011168 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 15313227 | ||
| Pubmed | Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. | 1.25e-06 | 3 | 23 | 2 | 28270609 | |
| Pubmed | The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. | 1.25e-06 | 3 | 23 | 2 | 1991046 | |
| Pubmed | Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice. | 1.25e-06 | 3 | 23 | 2 | 2354437 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 37659685 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 9271096 | ||
| Pubmed | 1.78e-06 | 36 | 23 | 3 | 9344654 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 1552159 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 22159897 | ||
| Pubmed | Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. | 2.51e-06 | 4 | 23 | 2 | 10049703 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 21161333 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 8334987 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 20427718 | ||
| Pubmed | Mapping of guanylin to murine chromosome 4 and human chromosome 1p34-p35. | 4.18e-06 | 5 | 23 | 2 | 7601480 | |
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 8363569 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 8798505 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 3166417 | ||
| Pubmed | Peroxisome proliferator-activated receptor-α accelerates α-chlorofatty acid catabolism. | 6.26e-06 | 6 | 23 | 2 | 28007964 | |
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 11461119 | ||
| Pubmed | Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping. | 6.26e-06 | 6 | 23 | 2 | 8661721 | |
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 1978328 | ||
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 12958197 | ||
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 18648086 | ||
| Pubmed | Microdissection and microcloning of mid-chromosome 4: genetic mapping of 41 microdissection clones. | 1.17e-05 | 8 | 23 | 2 | 8098006 | |
| Pubmed | Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. | 1.17e-05 | 8 | 23 | 2 | 18488193 | |
| Pubmed | Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice. | 1.50e-05 | 9 | 23 | 2 | 1685137 | |
| Pubmed | 1.50e-05 | 9 | 23 | 2 | 7678494 | ||
| Pubmed | Genetic mapping of meander tail, a mouse mutation affecting cerebellar development. | 1.88e-05 | 10 | 23 | 2 | 2037292 | |
| Pubmed | 3.25e-05 | 13 | 23 | 2 | 28137874 | ||
| Pubmed | 3.25e-05 | 13 | 23 | 2 | 32266253 | ||
| Pubmed | 3.25e-05 | 13 | 23 | 2 | 18722365 | ||
| Pubmed | 4.37e-05 | 15 | 23 | 2 | 29968852 | ||
| Pubmed | Exon structure of the nuclear factor I DNA-binding domain from C. elegans to mammals. | 4.99e-05 | 16 | 23 | 2 | 10087299 | |
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 22154759 | ||
| Pubmed | 5.66e-05 | 17 | 23 | 2 | 27197076 | ||
| Pubmed | Expression of murine cyclin B1 mRNAs and genetic mapping of related genomic sequences. | 6.36e-05 | 18 | 23 | 2 | 1387105 | |
| Pubmed | Loss of the neurodevelopmental gene Zswim6 alters striatal morphology and motor regulation. | 7.10e-05 | 19 | 23 | 2 | 28433741 | |
| Pubmed | 1.14e-04 | 24 | 23 | 2 | 7873878 | ||
| Pubmed | Molecular genetic linkage maps of mouse chromosomes 4 and 6. | 1.35e-04 | 26 | 23 | 2 | 1684952 | |
| Pubmed | Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia. | 1.45e-04 | 27 | 23 | 2 | 28167773 | |
| Pubmed | 1.68e-04 | 29 | 23 | 2 | 28364022 | ||
| Pubmed | Genetic mapping of six mouse peroxiredoxin genes and fourteen peroxiredoxin related sequences. | 2.90e-04 | 38 | 23 | 2 | 10501973 | |
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 3.89e-04 | 44 | 23 | 2 | 12745259 | |
| Pubmed | 5.65e-04 | 53 | 23 | 2 | 15306695 | ||
| Pubmed | Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. | 6.08e-04 | 55 | 23 | 2 | 24200680 | |
| Interaction | CYP4A22 interactions | 3.74e-06 | 3 | 23 | 2 | int:CYP4A22 | |
| Interaction | CYP4A11 interactions | 1.24e-05 | 5 | 23 | 2 | int:CYP4A11 | |
| Interaction | ZNF280B interactions | 1.86e-05 | 6 | 23 | 2 | int:ZNF280B | |
| Cytoband | 22q11.22 | 6.04e-05 | 23 | 23 | 2 | 22q11.22 | |
| Cytoband | 1p33 | 1.41e-04 | 35 | 23 | 2 | 1p33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p33 | 4.32e-04 | 61 | 23 | 2 | chr1p33 | |
| GeneFamily | Cytochrome P450 family 4 | 2.97e-04 | 36 | 13 | 2 | 1003 | |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN | 3.30e-05 | 10 | 23 | 2 | MM560 | |
| Coexpression | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP | 5.71e-05 | 13 | 23 | 2 | MM530 | |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP | 8.77e-05 | 16 | 23 | 2 | MM559 | |
| Disease | X-14939 measurement | 8.70e-06 | 6 | 23 | 2 | EFO_0800747 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 3.18e-05 | 11 | 23 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.20e-04 | 152 | 23 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.07e-03 | 62 | 23 | 2 | EFO_0022339 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.56e-03 | 75 | 23 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | cholesterol in large HDL measurement | 1.77e-03 | 80 | 23 | 2 | EFO_0021900 | |
| Disease | Hodgkins lymphoma | 1.86e-03 | 82 | 23 | 2 | EFO_0000183 | |
| Disease | rheumatoid arthritis | 5.35e-03 | 462 | 23 | 3 | EFO_0000685 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNDSWEDHTTCQHCH | 326 | P59817 | |
| NDSWENHTTCQHCHR | 336 | Q86YH2 | |
| CWNDGKHHHSQEIIE | 46 | A8K979 | |
| WTHRACQLAHQHTDQ | 251 | Q02928 | |
| ATHNNAVWNHCFIHR | 231 | Q8TCP9 | |
| QRNAFWVHHLHQEEI | 1046 | Q96QP1 | |
| RMEVCENHQHWHTVV | 156 | Q06481 | |
| ENHQHWHTVVKEACL | 161 | Q06481 | |
| PNTHCVWHIQVATDH | 166 | Q9BY79 | |
| VVWRHAHQIALQQHC | 251 | P46095 | |
| HLQAELHQHGCWTVT | 151 | Q6H9L7 | |
| RHWLTQFQTCHHSAD | 121 | Q8N159 | |
| HVHWAQQDCHLCSLI | 231 | Q9H799 | |
| WTHRACQLAHQHTDQ | 251 | Q5TCH4 | |
| RCLEHQQHWNHLDEE | 466 | Q05932 | |
| NESEHHWDMVRCHLQ | 566 | Q902F9 | |
| RHQEQEWQTVACAHH | 566 | A8K8P3 | |
| CWHCQARHELQHRVD | 131 | Q8IW70 | |
| IHLNNFHCHRGQEWI | 11 | Q9NWF9 | |
| WQEIHQACRFGHVQH | 251 | Q9BYB0 | |
| VSHVWVHDSCHANQL | 1826 | Q12888 | |
| RTHHDNWQEHKQQFT | 1811 | Q14997 | |
| CWENNHLVMHQRGHS | 196 | Q8N393 | |
| ACDLHWQDSHLQHII | 521 | Q9HCJ5 | |
| EFLDTWNRETHCHQH | 66 | P25942 |